Victoria Stepanova相关文献与解析，生知库

Yi Na Dong, Fu-Chun Hsu, Cynthia J Koziol-White, Victoria Stepanova, Joseph Jude, Andrei Gritsiuta, Ryan Rue, Rosalind Mott, Douglas A Coulter, Reynold A Panettieri Jr, Vera P Krymskaya, Hajime Takano, Elena A Goncharova, Dmitry A Goncharov, Douglas B Cines, David R Lynch

细胞生物学

其它细胞

ICC

FcRn augments induction of tissue factor activity by IgG-containing immune complexes

FcRn增强含IgG免疫复合物诱导组织因子活性的作用

期刊:Blood

影响因子:21

doi:10.1182/blood.2019001133

Douglas B Cines ，Sergei Zaitsev ，Lubica Rauova ，Ann H Rux ，Victoria Stepanova ，Sriram Krishnaswamy ，Amrita Sarkar ，M Anna Kowalska ，Guohua Zhao ，Alan E Mast ，Laurence J Blumberg ，Keith R McCrae ，Mortimer Poncz ，Jonathan J Hubbard ，Michal Pyzik ，Richard S Blumberg

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors

尿激酶型纤溶酶原激活剂 (uPA) 对结节性硬化症复合物 2 (TSC2) 缺陷型肿瘤的进展至关重要

期刊:Journal of Biological Chemistry

影响因子:4

doi:10.1074/jbc.M117.799593

Victoria Stepanova, Konstantin V Dergilev, Kelci R Holman, Yelena V Parfyonova, Zoya I Tsokolaeva, Mimi Teter, Elena N Atochina-Vasserman, Alla Volgina, Sergei V Zaitsev, Shane P Lewis, Fedor G Zabozlaev, Kseniya Obraztsova, Vera P Krymskaya, Douglas B Cines

Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression

尿激酶型纤溶酶原激活剂 (uPA) 通过减弱富含脯氨酸的同源域蛋白 (PRH) 转录因子活性和解除对血管内皮生长因子 (VEGF) 受体表达的抑制来促进血管生成。

期刊:Journal of Biological Chemistry

影响因子:4

doi:10.1074/jbc.M115.678490

Victoria Stepanova ，Padma-Sheela Jayaraman ，Sergei V Zaitsev ，Tatiana Lebedeva ，Khalil Bdeir ，Rachael Kershaw ，Kelci R Holman ，Yelena V Parfyonova ，Ekaterina V Semina ，Irina B Beloglazova ，Vsevolod A Tkachuk ，Douglas B Cines

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK

卵泡蛋白通过 E-钙粘蛋白、LKB1 和 AMPK 控制肺泡增大和上皮细胞存活

期刊:Cell Reports

影响因子:7.5

doi:10.1016/j.celrep.2014.03.025

Elena A Goncharova, Dmitry A Goncharov, Melane L James, Elena N Atochina-Vasserman, Victoria Stepanova, Seung-Beom Hong, Hua Li, Linda Gonzales, Masaya Baba, W Marston Linehan, Andrew J Gow, Susan Margulies, Susan Guttentag, Laura S Schmidt, Vera P Krymskaya

Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer

尿激酶型纤溶酶原激活剂 (uPA) 在胰腺癌癌症干细胞和化疗耐药中的多功能作用

期刊:Molecular Biology of the Cell

影响因子:3.1

doi:10.1091/mbc.E12-04-0306

Swapna Asuthkar, Victoria Stepanova, Tatiana Lebedeva, Aixuan L Holterman, Norman Estes, Douglas B Cines, Jasti S Rao, Christopher S Gondi

Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration

Fibulin-5 与尿激酶型纤溶酶原激活剂结合，并介导尿激酶刺激的 β1 整合素依赖性细胞迁移

期刊:Biochemical Journal

影响因子:4.4

doi:10.1042/BJ20110348

Alexander Kapustin, Victoria Stepanova, Natalia Aniol, Douglas B Cines, Alexei Poliakov, Serge Yarovoi, Tatiana Lebedeva, Robin Wait, Grigory Ryzhakov, Yelena Parfyonova, Yaroslav Gursky, Hiromi Yanagisawa, Mikhail Minashkin, Robert Beabealashvilli, Alexander Vorotnikov, Alex Bobik, Vsevolod Tkachuk

Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase

尿激酶型纤溶酶原激活剂 (uPA) 通过低密度脂蛋白受体相关蛋白 (LRP) 依赖的内皮型一氧化氮合酶激活来诱导肺微血管内皮通透性

期刊:Journal of Biological Chemistry

影响因子:4

doi:10.1074/jbc.M110.210195

Anastasia M Makarova, Tatiana V Lebedeva, Taher Nassar, Abd Al-Roof Higazi, Jing Xue, Maria E Carinato, Khalil Bdeir, Douglas B Cines, Victoria Stepanova

心血管

发表日期：2011

文献求助收藏

Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation

由在血凝块形成部位激活的红细胞靶向尿激酶原介导的持续性血栓预防

期刊:Blood

影响因子:21

doi:10.1182/blood-2010-01-261610

Sergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, Bi-Sen Ding, Samira Tliba, M Anna Kowalska, Oscar A Marcos-Contreras, Alice Kuo, Victoria Stepanova, John P Atkinson, Mortimer Poncz, Douglas B Cines, Vladimir R Muzykantov

Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis

将突变型纤溶酶原激活剂靶向循环红细胞以进行预防性纤维蛋白溶解

期刊:Journal of Pharmacology and Experimental Therapeutics

影响因子:3.1

doi:10.1124/jpet.109.159194

Sergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, Bi-Sen Ding, Samira Tliba, M Anna Kowalska, Khalil Bdeir, Alice Kuo, Victoria Stepanova, John P Atkinson, Mortimer Poncz, Douglas B Cines, Vladimir R Muzykantov

Functional NMDA receptors are expressed by human pulmonary artery smooth muscle cells

功能性 NMDA 受体由人类肺动脉平滑肌细胞表达

FcRn augments induction of tissue factor activity by IgG-containing immune complexes

FcRn增强含IgG免疫复合物诱导组织因子活性的作用

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors

尿激酶型纤溶酶原激活剂 (uPA) 对结节性硬化症复合物 2 (TSC2) 缺陷型肿瘤的进展至关重要

Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression

尿激酶型纤溶酶原激活剂 (uPA) 通过减弱富含脯氨酸的同源域蛋白 (PRH) 转录因子活性和解除对血管内皮生长因子 (VEGF) 受体表达的抑制来促进血管生成。

Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK

卵泡蛋白通过 E-钙粘蛋白、LKB1 和 AMPK 控制肺泡增大和上皮细胞存活

Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer

尿激酶型纤溶酶原激活剂 (uPA) 在胰腺癌癌症干细胞和化疗耐药中的多功能作用

Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration

Fibulin-5 与尿激酶型纤溶酶原激活剂结合，并介导尿激酶刺激的 β1 整合素依赖性细胞迁移

Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase

尿激酶型纤溶酶原激活剂 (uPA) 通过低密度脂蛋白受体相关蛋白 (LRP) 依赖的内皮型一氧化氮合酶激活来诱导肺微血管内皮通透性

Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation

由在血凝块形成部位激活的红细胞靶向尿激酶原介导的持续性血栓预防

Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis

将突变型纤溶酶原激活剂靶向循环红细胞以进行预防性纤维蛋白溶解